ISRG vs VRTX: Which Stock Is the Better Buy?
Intuitive Surgical, Inc. and Vertex Pharmaceuticals Incorporated side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — ISRG vs VRTX, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Intuitive Surgical, Inc. (ISRG) | Vertex Pharmaceuticals Incorporated (VRTX) | |
|---|---|---|
| Market cap | $126.6B | $121.1B |
| Revenue (latest FY) | $10.06B | $12.00B |
| Net income (latest FY) | $2.86B | $3.95B |
| Revenue growth (5y CAGR) | 18.2% | 14.1% |
| Net margin | 28.4% | 32.9% |
| Return on equity | 16.0% | 21.2% |
| P/E ratio | 40.5 | 28.3 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 10 | 8 |
| Positive free cash flow | Yes | Yes |
Verify the comparison
Use the filing period and source shown by each tool before treating two figures as comparable.
See the full ISRG vs VRTX breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open ISRG's full financials → Open VRTX's full financials →More comparisons
Frequently asked questions
Which is bigger, ISRG or VRTX?
Intuitive Surgical, Inc. is larger by market capitalization — $126.6B versus $121.1B.
Which grows faster, ISRG or VRTX?
Over the last five fiscal years, Intuitive Surgical, Inc. grew revenue faster — 18.2%/yr versus 14.1%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.